Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Neuroreport 2:34547, PMID: 1832987 Owe SG, Marcaggi P, Attwell D (2006) The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia
Semaglutide, a GLP-1 receptor agonist, mimics the natural incretin hormone GLP-1 to enhance insulin secretion, slow gastric emptying, and increase satiety
Gastric electrical stimulation (the Enterra device) is FDA-approved under humanitarian device exemption but shows mixed results in clinical trials (McCallum et al., Gastroenterology, 2010)
Here's the mechanism: after 8-10 hours of fasting, your body needs amino acids (from protein) to trigger muscle protein synthesis
Quick Comparison: Sleeve vs Bypass The table below summarizes common differences, but your personal recommendation should come from a bariatric consultation
Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
